List of FDA-approvedpeptidesPDF The landscape of peptides approved by the FDA is complex, encompassing a growing number of therapeutic agents that have undergone rigorous testing for safety and efficacy.Guidance for Industry- Synthetic Peptides While many peptides are naturally occurring or synthesized for research purposes, only a select few have earned the FDA's stamp of approval for medical use, signifying their proven benefit in treating various conditionsAre Peptides FDA-approved?. Understanding which peptides are officially recognized by the FDA is crucial for healthcare professionals and patients alike, distinguishing them from unregulated compounds that may pose significant health risks.
The Food and Drug Administration (FDA) has approved a substantial and increasing number of peptides for therapeutic use. These approved peptides span a range of medical applications, from managing chronic diseases to treating specific cancers and hormonal imbalances. The journey from discovery to FDA approval is a lengthy and demanding process, involving extensive preclinical research, multiple phases of clinical trials, and stringent manufacturing standards. This ensures that approved peptide drugs meet high benchmarks for safety, efficacy, and quality.
Recent years have seen a notable uptick in the approval of peptide-based drugs.'People are turning themselves into lab rats': the injectable ... For instance, in 2023 and 2024, several novel peptides and oligonucleotides (often referred to as TIDEs) have received FDA clearance, highlighting a dynamic area of pharmaceutical development. These include synthetic peptides like Motixafortide (Aphexda®), approved in September 2023 for use in multiple myeloma, and cyclic peptides such as Rezafungin, also approved in 2023 for candidemia. The FDA's commitment to advancing peptide therapeutics is further evidenced by ongoing guidance documents for industry, aimed at facilitating the development and approval of these complex molecules.
FDA-approved peptides can be broadly categorized by their therapeutic indications. Some of the most prominent examples include:
* Diabetes Management: GLP-1 receptor agonists are among the most well-known FDA-approved peptide drugs for managing type 2 diabetes and, in some cases, for weight loss.作者：O Al Musaimi·2024·被引用次数：36—Since 1923, the FDA has approved approximatelyten natural peptides for various indications, nine peptides for diabetes, four growth hormone-releasing hormones ... Medications like semaglutide and tirzepatide fall into this class, mimicking the action of naturally occurring hormones to regulate blood sugar and appetite.
* Hormone Replacement and Stimulation: Peptides that influence hormone levels are also well-representedTHPdb: A Database of FDA approved Therapeutic .... Insulin, a naturally occurring peptide, is a cornerstone treatment for diabetes. Growth hormone-releasing hormones and their analogs are approved for conditions related to growth deficiencies.
* Cancer Treatment: Certain peptides are utilized in oncology, either directly as therapeutic agents or as components of treatment regimens. For example, Tebentafusp, Buserelin, Plitidepsin, Triptorelin, and Dactinomycin are among the FDA-approved peptides used in various cancer therapies.
* Other Indications: The spectrum of approved peptides extends to other areas.Are Peptides Legal in the U.S.? - Florida Healthcare Law Firm Teriparatide injection, an early generic peptide, is used for osteoporosis. Atracurium and Ziconotide are examples of peptides derived from natural sources (like venom) that have been approved for specific medical uses, such as muscle relaxation during surgery and managing severe pain, respectivelyThe Ultimate Guide to Peptides 2025: Types, Benefits, and .... Captopril, an ACE inhibitor, is also a peptide-based drug, primarily used for hypertension.
A critical distinction exists between FDA-approved peptides and those marketed for research or wellness purposes without regulatory oversightGuidance for Industry- Synthetic Peptides. The rise of "wellness peptides" and compounds like BPC-157, GHK-Cu, and Melanotan II, often promoted online and through social media, has raised significant concerns. These substances, while sometimes touted for benefits like recovery, muscle growth, or anti-aging, have not undergone the rigorous FDA approval processCompounded injectable drugs containing GHK-Cu may pose risk for immunogenicity due to the potential for aggregation and peptide-related impurities..
The FDA has explicitly warned against the use of many such unapproved peptides, emphasizing that they are not regulated drugs and can carry serious health risks, including potential immunogenicity, unpredictable side effects, and contamination. The agency has also taken action against the compounding of certain peptides, particularly when they are not FDA-approved for that specific use or when such compounding raises safety concerns. For instance, injectable drugs containing GHK-Cu have been flagged for potential immunogenicity due to aggregation and impurities.5 Best Peptide Companies: Trusted Online Vendors in 2025
For individuals considering peptide therapy, it is paramount to consult with a qualified healthcare provider. They can guide patients toward FDA-approved treatment options and explain the risks and benefits associated with them. Information from sources like THPdb and THPdb2, which compile databases of FDA-approved therapeutic peptides and proteins, can be invaluable for understanding the current approved landscape.
The regulatory environment for peptides is continually evolving... Currently, there are fiveapprovedACPs named Tebentafusp, Buserelin, Plitidepsin, Triptorelin, and Dactinomycin, and several are under clinical trials.. While guidance for industry on synthetic peptide development and assessment of peptide-related impurities is available, the line between legitimate therapeutic use and unregulated markets remains a significant concern.Immunogenicity Assessments in Peptides The FDA's stance is clear: only peptides that have successfully navigated the stringent approval process can be considered safe and effective for medical treatment作者：M Baradaran·被引用次数：15—Currently, there are not many venom-based peptide therapeutics approved by the FDA. Some of the most important ones arecaptopril, atracurium, ziconotide, and .... This ensures that patients receive treatments backed by scientific evidence and regulatory assurance, prioritizing their health and well-being above unproven claims.
Join the newsletter to receive news, updates, new products and freebies in your inbox.